Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiological Study on Drug-induced Coagulation Disorder Caused by Cefoperazone Sulbactam Sodium and Construction of Prediction Model

NCT05535309 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT05535309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05535309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiological Study on Drug-induced Coagulation Disorder Caused by Cefoperazone Sulbactam Sodium and Construction of Prediction Model
Lead sponsor
Qianfoshan Hospital
Phase
Observational
Overall status
Completed
Start date
November 2, 2021
Completion date
December 30, 2023
Enrollment
8,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

risk factors